• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达格列净可减轻小鼠氧化应激、炎症和衰老的组织病理学标志物。

Dapagliflozin mitigates oxidative stress, inflammatory, and histopathological markers of aging in mice.

机构信息

Department of Pharmacology, College of Pharmacy, Al-Esraa University, Baghdad, Iraq.

Department of Clinical Pharmacy, College of Pharmacy, Al-Nahrain University, Baghdad, Iraq.

出版信息

J Med Life. 2024 Feb;17(2):157-163. doi: 10.25122/jml-2023-0343.

DOI:10.25122/jml-2023-0343
PMID:38813367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11131629/
Abstract

Aging, a complex physiological process affecting all living things, is a major area of research, particularly focused on interventions to slow its progression. This study assessed the antiaging efficacy of dapagliflozin (DAPA) on various aging-related parameters in a mouse model artificially induced to age. Forty male Swiss albino mice were randomly divided into four groups of ten animals each. The control group (Group I) received normal saline. The aging model group (Group II) was administered D-galactose orally at 500mg/kg to induce aging. Following the aging induction, the positive control group received Vitamin C supplementation (Group III), while the DAPA group (Group IV) was treated with dapagliflozin. The inflammatory mediators (TNF-α and IL-1β) showed similar patterns of change. No statistically significant difference was observed between groups III and IV. Both groups had significantly lower values compared to GII, while it was significantly higher compared to GI. Glutathione peroxidase (GSH-Px) showed no statistically significant difference between groups GIII and GIV, but it was higher in GIII compared to GII and significantly lower in GIII compared to GI. The study demonstrated that dapagliflozin exerts a beneficial impact on many indicators of aging in mice. The intervention resulted in a reduction in hypertrophy in cardiomyocytes, an enhancement in skin vitality, a decrease in the presence of inflammatory mediators, and an improvement in the efficacy of antioxidants.

摘要

衰老,一种影响所有生物的复杂生理过程,是一个主要的研究领域,特别是集中在干预措施以减缓其进展。本研究评估了达格列净(DAPA)对人工诱导衰老的小鼠模型中各种与衰老相关参数的抗衰老疗效。40 只雄性瑞士白化病小鼠被随机分为四组,每组 10 只动物。对照组(I 组)给予生理盐水。衰老模型组(II 组)给予 500mg/kg 的 D-半乳糖口服以诱导衰老。衰老诱导后,阳性对照组给予维生素 C 补充(III 组),而 DAPA 组(IV 组)给予达格列净治疗。炎症介质(TNF-α和 IL-1β)表现出相似的变化模式。III 组和 IV 组之间没有统计学差异。与 GII 相比,两组的数值均显著降低,而与 GI 相比,两组的数值均显著升高。谷胱甘肽过氧化物酶(GSH-Px)在 GIII 和 GIV 组之间没有统计学差异,但与 GII 相比,GIII 组的数值更高,与 GI 相比,GIII 组的数值显著更低。研究表明,达格列净对小鼠的许多衰老指标都有有益的影响。该干预措施导致心肌细胞肥大减少,皮肤活力增强,炎症介质的存在减少,抗氧化剂的功效改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/28b5f2e6aeab/JMedLife-17-157-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/31d219b6f0d1/JMedLife-17-157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/48e65797528e/JMedLife-17-157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/e01161b4bda1/JMedLife-17-157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/8c525e580be2/JMedLife-17-157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/28b5f2e6aeab/JMedLife-17-157-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/31d219b6f0d1/JMedLife-17-157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/48e65797528e/JMedLife-17-157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/e01161b4bda1/JMedLife-17-157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/8c525e580be2/JMedLife-17-157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c8/11131629/28b5f2e6aeab/JMedLife-17-157-g005.jpg

相似文献

1
Dapagliflozin mitigates oxidative stress, inflammatory, and histopathological markers of aging in mice.达格列净可减轻小鼠氧化应激、炎症和衰老的组织病理学标志物。
J Med Life. 2024 Feb;17(2):157-163. doi: 10.25122/jml-2023-0343.
2
Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation.达格列净通过抑制氧化应激和炎症改善糖尿病大鼠的脂肪性肝炎。
Int Immunopharmacol. 2022 Mar;104:108503. doi: 10.1016/j.intimp.2021.108503. Epub 2022 Jan 5.
3
Potential anti-inflammatory effect of dapagliflozin in HCHF diet- induced fatty liver degeneration through inhibition of TNF-α, IL-1β, and IL-18 in rat liver.达格列净通过抑制大鼠肝脏中的肿瘤坏死因子-α、白细胞介素-1β和白细胞介素-18对高碳水化合物高脂肪饮食诱导的脂肪肝变性的潜在抗炎作用。
Int Immunopharmacol. 2020 Sep;86:106730. doi: 10.1016/j.intimp.2020.106730. Epub 2020 Jun 26.
4
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.钠-葡萄糖协同转运蛋白 2 抑制剂达格列净可预防西方饮食诱导肥胖小鼠的肾脏和肝脏疾病。
Int J Mol Sci. 2018 Jan 3;19(1):137. doi: 10.3390/ijms19010137.
5
Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis.钠-葡萄糖协同转运蛋白 2 抑制剂达格列净对大鼠糖尿病肾病的作用:炎症、血管生成和细胞凋亡。
Life Sci. 2021 Sep 1;280:119018. doi: 10.1016/j.lfs.2021.119018. Epub 2021 Feb 5.
6
Protective effects and mechanisms of dapagliflozin on renal ischemia/reperfusion injury.达格列净对肾脏缺血/再灌注损伤的保护作用及机制
Transpl Immunol. 2024 Jun;84:102010. doi: 10.1016/j.trim.2024.102010. Epub 2024 Feb 5.
7
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.钠-葡萄糖共转运蛋白 2 抑制剂达格列净可减轻糖尿病心肌病。
Cardiovasc Diabetol. 2020 Jan 10;19(1):7. doi: 10.1186/s12933-019-0980-4.
8
Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.长期使用钠-葡萄糖协同转运蛋白2抑制剂达格列净治疗可改善db/db小鼠的葡萄糖稳态和糖尿病肾病。
PLoS One. 2014 Jun 24;9(6):e100777. doi: 10.1371/journal.pone.0100777. eCollection 2014.
9
The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE Mice.钠-葡萄糖协同转运蛋白2抑制剂达格列净对糖尿病载脂蛋白E基因敲除小鼠的动脉粥样硬化具有治疗作用。
Mediators Inflamm. 2016;2016:6305735. doi: 10.1155/2016/6305735. Epub 2016 Dec 26.
10
Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.联合 SGLT2 和 DPP4 抑制可减少 2 型糖尿病小鼠 NLRP3/ASC 炎性小体的激活并减轻糖尿病肾病的发展。
Cardiovasc Drugs Ther. 2018 Apr;32(2):135-145. doi: 10.1007/s10557-018-6778-x.

引用本文的文献

1
TLR-4/Notch1/NF-κB pathway modulation by dapagliflozin: a novel mechanism for neuroprotection in hepatic encephalopathy.达格列净对TLR-4/Notch1/NF-κB信号通路的调节作用:肝性脑病神经保护的新机制
Metab Brain Dis. 2025 Sep 8;40(7):260. doi: 10.1007/s11011-025-01681-z.
2
SGLT2 Inhibitors in Glomerulonephritis: Beyond Nephroprotection?肾小球肾炎中的SGLT2抑制剂:超越肾脏保护作用?
J Clin Med. 2025 May 18;14(10):3533. doi: 10.3390/jcm14103533.
3
Synthetic and Natural Agents Targeting Advanced Glycation End-Products for Skin Anti-Aging: A Comprehensive Review of Experimental and Clinical Studies.

本文引用的文献

1
Dapagliflozin attenuates myocardial hypertrophy via activating the SIRT1/HIF-1α signaling pathway.达格列净通过激活 SIRT1/HIF-1α 信号通路减轻心肌肥厚。
Biomed Pharmacother. 2023 Sep;165:115125. doi: 10.1016/j.biopha.2023.115125. Epub 2023 Jul 6.
2
Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.达格列净通过调节 IL6/STAT3 和 TLR2/TNFα 信号通路防止镉诱导的心脏毒性。
Cardiovasc Toxicol. 2022 Nov;22(10-11):916-928. doi: 10.1007/s12012-022-09768-0. Epub 2022 Oct 15.
3
Skin Dryness Induced in the KK-Ay/TaJcl Type 2 Diabetes Mouse Model Deteriorates Following Dapagliflozin Administration.
针对晚期糖基化终产物的合成与天然皮肤抗衰剂:实验与临床研究综述
Antioxidants (Basel). 2025 Apr 20;14(4):498. doi: 10.3390/antiox14040498.
4
Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy.综合组学对达格列净在脓毒症诱导的心肌病中作用的见解
Biomolecules. 2025 Feb 14;15(2):286. doi: 10.3390/biom15020286.
5
Mitigative Effects of Topical Norfloxacin on an Imiquimod-Induced Murine Model of Psoriasis.外用诺氟沙星对咪喹莫特诱导的银屑病小鼠模型的缓解作用。
ACS Pharmacol Transl Sci. 2024 Aug 2;7(9):2739-2754. doi: 10.1021/acsptsci.4c00152. eCollection 2024 Sep 13.
6
The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation.卡格列净对咪喹莫特诱导的银屑病样炎症小鼠模型的缓解作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2695-2715. doi: 10.1007/s00210-024-03406-y. Epub 2024 Sep 10.
7
Azilsartan as a preventive agent against cyclophosphamide-induced testicular injury in male rats.阿齐沙坦作为雄性大鼠环磷酰胺诱导的睾丸损伤的预防剂。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):979-990. doi: 10.1007/s00210-024-03339-6. Epub 2024 Aug 2.
在 KK-Ay/TaJcl 型 2 型糖尿病小鼠模型中诱导的皮肤干燥在给予达格列净后恶化。
Biol Pharm Bull. 2022 Jul 1;45(7):934-939. doi: 10.1248/bpb.b22-00241. Epub 2022 May 17.
4
Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis.达格列净和利拉鲁肽对糖尿病诱导大鼠心肌病的作用:氧化应激、炎症和细胞凋亡的影响。
Front Endocrinol (Lausanne). 2022 Mar 18;13:862394. doi: 10.3389/fendo.2022.862394. eCollection 2022.
5
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.钠-葡萄糖协同转运蛋白 2 抑制剂达格列净可预防实验性 1 型糖尿病的动脉粥样硬化和心脏并发症。
PLoS One. 2022 Feb 17;17(2):e0263285. doi: 10.1371/journal.pone.0263285. eCollection 2022.
6
Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated macrophages.达格列净通过抑制 LPS 诱导的人内皮细胞和分化巨噬细胞中 TLR-4 的过度表达和 NF-κB 激活发挥抗炎作用。
Eur J Pharmacol. 2022 Mar 5;918:174715. doi: 10.1016/j.ejphar.2021.174715. Epub 2022 Jan 11.
7
Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.达格列净:钠-葡萄糖共转运蛋白 2 抑制剂,通过调节 TGFβ1/Smad 信号通路减轻血管紧张素 II 诱导的心肌成纤维细胞重塑。
Cardiovasc Diabetol. 2021 Jun 11;20(1):121. doi: 10.1186/s12933-021-01312-8.
8
Exploration of the optimal strategy for dietary calcium intervention against the toxicity of liver and kidney induced by cadmium in mice: An in vivo diet intervention study.探索膳食钙干预对抗镉致肝肾毒性的最佳策略:一项体内饮食干预研究。
PLoS One. 2021 May 11;16(5):e0250885. doi: 10.1371/journal.pone.0250885. eCollection 2021.
9
Potential anti-inflammatory effect of dapagliflozin in HCHF diet- induced fatty liver degeneration through inhibition of TNF-α, IL-1β, and IL-18 in rat liver.达格列净通过抑制大鼠肝脏中的肿瘤坏死因子-α、白细胞介素-1β和白细胞介素-18对高碳水化合物高脂肪饮食诱导的脂肪肝变性的潜在抗炎作用。
Int Immunopharmacol. 2020 Sep;86:106730. doi: 10.1016/j.intimp.2020.106730. Epub 2020 Jun 26.
10
Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.达格列净和替格瑞洛对 NLRP3 炎性小体激活和糖尿病心肌病进展的抑制作用具有相加效应:AMPK-mTOR 相互作用。
Cardiovasc Drugs Ther. 2020 Aug;34(4):443-461. doi: 10.1007/s10557-020-06978-y.